BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Diagnosis
5523 results:

  • 1. Risk of second primary thyroid cancer in cancer survivors.
    Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
    Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
    Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
    Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical and Paraclinical Considerations Regarding ki67's Role in the Management of Differentiated thyroid Carcinoma-A Literature Review.
    Peștean C; Pavel A; Piciu D
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792952
    [No Abstract]    [Full Text] [Related]  

  • 4. Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok.
    Thewjitcharoen Y; Chatchomchuan W; Wanothayaroj E; Butadej S; Nakasatien S; Krittiyawong S; Rajatanavin R; Himathongkam T
    Medicine (Baltimore); 2024 May; 103(21):e38290. PubMed ID: 38788029
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [The relationship between differentially expressed thyroid cancer genes and clinical characteristics in metastatic children and adolescents].
    Pan YJ; Ju GD; Mu ZZ; Sun YQ; Sun D; Liang J; Lin YS
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1837-1843. PubMed ID: 38782752
    [No Abstract]    [Full Text] [Related]  

  • 6. Use superb microvascular imaging to diagnose and predict metastatic cervical lymph nodes in patients with papillary thyroid carcinoma.
    Huang T; Huang PT; Luo ZY; Lv JF; Jin PL; Zhang T; Zhao YL; Wang Y; Hong YR
    J Cancer Res Clin Oncol; 2024 May; 150(5):268. PubMed ID: 38772976
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of thyroid cancer.
    Fu G; Chazen RS; MacMillan C; Witterick IJ
    JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Imaging characteristics and diagnosis of primary middle mediastinal tumors].
    Chen JQ; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):449-456. PubMed ID: 38742358
    [No Abstract]    [Full Text] [Related]  

  • 10. Association between diabetes and subsequent malignancy risk among older breast cancer survivors.
    Hardell KNL; Schonfeld SJ; Ramin C; Vo JB; Morton LM
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38718185
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
    Park J; An S; Bae JS; Kim JS; Kim K
    Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A comparison of swallowing related quality of life in patients undergoing transoral endoscopic versus open thyroid surgery.
    Deshmukh P; Shiva B; Yadav SK; Agarwal P; Sharma D; Johri G
    World J Surg; 2024 Feb; 48(2):379-385. PubMed ID: 38686757
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ultrasound and cytopathological characteristics of thyroid tumours of uncertain malignant potential - from diagnosis to treatment.
    Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Góralski P; Gałczyński J; Bakuła-Zalewska E; Dedecjus M
    Endokrynol Pol; 2024; 75(2):170-178. PubMed ID: 38646986
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. thyroid nodule rupture after radiofrequency ablation: case report and literature review.
    Ferraro T; Sajid S; Hodak SP; Baldwin CK
    Front Endocrinol (Lausanne); 2024; 15():1355383. PubMed ID: 38628591
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview study.
    D'souza B; Glover A; Bavor C; Brown B; Dodd RH; Lee JC; Millar J; Miller JA; Zalcberg JR; Serpell J; Ioannou LJ; Nickel B
    BMJ Open; 2024 Apr; 14(4):e069236. PubMed ID: 38626980
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.
    Han J; Gao J; Chen D; Du M; Wu Y; Ma X; Xie M; Han H; Wu C; Xue X
    Clin Respir J; 2024 Apr; 18(4):e13750. PubMed ID: 38616354
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association between Consumption of Iodine-Rich Foods and thyroid cancer Prevalence: Findings from a Large Population-Based Study.
    Kwon YJ; Lee HS; Kang SW; Lee JW
    Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613074
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Diagnostic value of contrast-enhanced ultrasound in the diagnosis of papillary thyroid microcarcinoma: A systematic review and meta-analysis.
    Ding Y; Peng Y; Zhang J; Pan X; Huang X; Zhang CQ
    Medicine (Baltimore); 2024 Apr; 103(15):e37768. PubMed ID: 38608080
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China.
    Le K; Jin L; Zhong F; Huang X; Zhou L; Zhou J; Xie L
    Front Endocrinol (Lausanne); 2024; 15():1359621. PubMed ID: 38577570
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Japanese Breast cancer Society Clinical Practice Guidelines for Breast cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.
    Yamamoto Y; Yamauchi C; Toyama T; Nagai S; Sakai T; Kutomi G; Yoshimura M; Kawai M; Ohtani S; Kubota K; Nakashima K; Honma N; Yoshida M; Tokunaga E; Taira N; Iwata H; Saji S
    Breast Cancer; 2024 May; 31(3):340-346. PubMed ID: 38570435
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 277.